{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T17:49:20Z","timestamp":1724089760029},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2011,11,21]],"date-time":"2011-11-21T00:00:00Z","timestamp":1321833600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0028112","type":"journal-article","created":{"date-parts":[[2011,11,21]],"date-time":"2011-11-21T22:05:30Z","timestamp":1321913130000},"page":"e28112","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":15,"title":["Toxicity Associated with Stavudine Dose Reduction from 40 to 30 mg in First-Line Antiretroviral Therapy"],"prefix":"10.1371","volume":"6","author":[{"given":"Mar","family":"Pujades-Rodr\u00edguez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuelle","family":"Dantony","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loretxu","family":"Pinoges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren\u00e9","family":"Ecochard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Fran\u00e7ois","family":"Etard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Carrillo-Casas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Szumilin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the AIDS Working Group of M\u00e9decins Sans Fronti\u00e8res","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2011,11,21]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1093\/infdis\/171.Supplement_2.S118","article-title":"Design and implementation of the stavudine parallel-track program.","volume":"171","author":"RE Anderson","year":"1995","journal-title":"J Infect Dis"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/infdis\/167.1.21","article-title":"2\u2032,3\u2032-didehydro-3\u2032-deoxythymidine (d4T) in patients with AIDS or AIDS-related complex: a phase I trial.","volume":"167","author":"MJ Browne","year":"1993","journal-title":"J Infect Dis"},{"key":"ref3","first-page":"abstract no.749","article-title":"Reduction of d4T dosage improves lipoatrophy without virologic failure.IAS Conference on HIV Pathogenesis and Treatment (2nd:2003: Paris, France).","volume":"8","author":"M Hanvanich","year":"2003","journal-title":"Antivir Ther"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1093\/infdis\/171.Supplement_2.S131","article-title":"Dose-related activity of stavudine in patients infected with human immunodeficiency virus.","volume":"171","author":"EA Petersen","year":"1995","journal-title":"J Infect Dis"},{"key":"ref5","article-title":"A randomized study comparing the efficacy and tolerability of low-dose versus standard-dose stavudine in antiretroviral-na\u00efve patients (ETOX Study).","volume":"4C10","author":"E Ribera","year":"2011","journal-title":"Abstract no TuPe2"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1097\/00002030-200211080-00002","article-title":"HIV-associated sensory neuropathies.","volume":"16","author":"SC Keswani","year":"2002","journal-title":"AIDS"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1097\/00002030-199818000-00011","article-title":"Neuromuscular function in HIV infection: analysis of a placebo-controlled combination antiretroviral trial. AIDS Clinical Group 175\/801 Study Team.","volume":"12","author":"DM Simpson","year":"1998","journal-title":"AIDS"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1517\/14656566.8.5.679","article-title":"Systematic review of clinical trials evaluating low doses of stavudine as part of antiretroviral treatment.","volume":"8","author":"A Hill","year":"2007","journal-title":"Expert Opin Pharmacother"},{"key":"ref9","article-title":"Addendum to 2006 WHO guidelines on antiretroviral therapy for HIV infection in adults and adolescents: new dosage recommendations for stavudine (d4T)."},{"key":"ref10","article-title":"Towards universal access: scaling up priority HIV\/AIDS interventions in the health sector."},{"key":"ref11","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/QAI.0b013e31817ae5ef","article-title":"Cost and cost-effectiveness of switching from stavudine to tenofovir in first-line antiretroviral regimens in South Africa.","volume":"48","author":"S Rosen","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/jama.2010.980","article-title":"Treatment failure and mortality factors in patients receiving second-line HIV therapy in resource-limited countries.","volume":"304","author":"M Pujades-Rodriguez","year":"2010","journal-title":"JAMA"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/QAD.0b013e328345889d","article-title":"Peripheral neuropathy in HIV: prevalence and risk factors.","volume":"25","author":"SR Evans","year":"2011","journal-title":"AIDS"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1086\/426076","article-title":"Modification of the incidence of drug-associated symmetrical peripheral neuropathy by host and disease factors in the HIV outpatient study cohort.","volume":"40","author":"KA Lichtenstein","year":"2005","journal-title":"Clin Infect Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1212\/WNL.0b013e3181f4d5bb","article-title":"Neurologic disease burden in treated HIV\/AIDS predicts survival: a population-based study.","volume":"75","author":"P Vivithanaporn","year":"2010","journal-title":"Neurology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1351-5101.2003.00713.x","article-title":"Risk modifiers for peripheral sensory neuropathy in HIV infection\/AIDS.","volume":"11","author":"OL Lopez","year":"2004","journal-title":"Eur J Neurol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1212\/WNL.58.12.1764","article-title":"Incidence of and risk factors for HIV-associated distal sensory polyneuropathy.","volume":"58","author":"G Schifitto","year":"2002","journal-title":"Neurology"},{"key":"ref18","first-page":"199","article-title":"Lipodystrophy and dyslipidemia among patients taking first-line, World Health Organization-recommended highly active antiretroviral therapy regimens in Western India.","volume":"39","author":"SN Pujari","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/QAI.0b013e31819c16f4","article-title":"Lipodystrophy and metabolic disorders in HIV-1-infected adults on 4- to 9-year antiretroviral therapy in Senegal: a case-control study.","volume":"51","author":"S Mercier","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref20","article-title":"Low dose stavudine: less side effects but as effective as standard dose.","volume":"WePeB5861","author":"E Wolf","year":"2004","journal-title":"Abstract no"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1468-1293.2008.00616.x","article-title":"Viral efficacy maintained and safety parameters improved with a reduced dose of stavudine: a pilot study.","volume":"9","author":"H Ait-Mohand","year":"2008","journal-title":"HIV Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1177\/135965350701200301","article-title":"The impact of reducing stavudine dose versus switching to tenofovir on plasma lipids, body composition and mitochondrial function in HIV-infected patients.","volume":"12","author":"A Milinkovic","year":"2007","journal-title":"Antivir Ther"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1310\/ED57-EU48-RK6A-E5U0","article-title":"Reductions in stavudine dose might ameliorate mitochondrial-associated complications without compromising antiviral activity.","volume":"6","author":"M Sanchez-Conde","year":"2005","journal-title":"HIV Clin Trials"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1002\/jmv.20676","article-title":"Gender and long-term metabolic toxicities from antiretroviral therapy in HIV-1 infected persons.","volume":"78","author":"MR Boulassel","year":"2006","journal-title":"J Med Virol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1001\/archneur.56.1.84","article-title":"Peripheral nerve function in HIV infection: clinical, electrophysiologic, and laboratory findings.","volume":"56","author":"M Tagliati","year":"1999","journal-title":"Arch Neurol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.pain.2010.08.045","article-title":"Association of self-reported painful symptoms with clinical and neurophysiologic signs in HIV-associated sensory neuropathy.","volume":"151","author":"J Robinson-Papp","year":"2010","journal-title":"Pain"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1258\/095646206777689062","article-title":"Distal sensory polyneuropathy in HIV-positive patients in the HAART era: an entity underestimated by clinical examination.","volume":"17","author":"EE Skopelitis","year":"2006","journal-title":"Int J STD AIDS"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1212\/WNL.52.3.607","article-title":"Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy.","volume":"52","author":"EA Childs","year":"1999","journal-title":"Neurology"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1212\/01.wnl.0000218303.48113.5d","article-title":"HIV neuropathy natural history cohort study: assessment measures and risk factors.","volume":"66","author":"DM Simpson","year":"2006","journal-title":"Neurology"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1097\/00002030-200306130-00007","article-title":"Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy.","volume":"17","author":"D Nolan","year":"2003","journal-title":"AIDS"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"33426","DOI":"10.1074\/jbc.274.47.33426","article-title":"Threshold effect and tissue specificity. Implication for mitochondrial cytopathies.","volume":"274","author":"R Rossignol","year":"1999","journal-title":"J Biol Chem"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1086\/529384","article-title":"Effect of reducing the dose of stavudine on body composition, bone density, and markers of mitochondrial toxicity in HIV-infected subjects: a randomized, controlled study.","volume":"46","author":"GA McComsey","year":"2008","journal-title":"Clin Infect Dis"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0028112","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,11]],"date-time":"2023-06-11T07:37:09Z","timestamp":1686469029000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0028112"}},"subtitle":[],"editor":[{"given":"Robert J.","family":"Wilkinson","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2011,11,21]]},"references-count":32,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2011,11,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0028112","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2011,11,21]]}}}